Company / CapEx per Share
Maze Therapeutics, Inc. CapEx per Share History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.32
FY2025
5-year range
$0.32 / $0.32
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#37 of 192
Health Care
What the data says
Maze Therapeutics, Inc.'s capex per share of $0.32 is higher than 81% of companies in the Health Care sector (FY2025).
Based on SEC 10-K filings.
0.32 in FY2025. Top quartile in the Health Care sector.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 19% in Health CareTop 19% of 192This company $0.32 Sector average $3.54
▼
-90.8% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.32 | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026